EGFR and carcinoma: In line with this, CD27xEGFR demonstrated selective and simultaneous binding to EGFR and CD27, with clear doublet formation of carcinoma and T cells and inhibition of binding upon pre-incubation with excess amounts of mAb 425 and CD27 mAb.